ENTRADA THERAPEUTICS, INC. Operating Lease Liability
ENTRADA THERAPEUTICS, INC. (TRDA) had Operating Lease Liability of $50.93 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-02-26
- 2025-12-31: Operating Lease, Liability $50.93M.
- 2024-12-31: Operating Lease, Liability $59.21M.
- 2023-12-31: Operating Lease, Liability $68.23M.
- 2023-09-30: Operating Lease, Liability $69.07M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $50.93M 10-K · filed 2026-02-26 |
| 2024-12-31 | $59.21M 10-K · filed 2025-02-27 |
| 2023-12-31 | $68.23M 10-K · filed 2024-03-13 |
| 2023-09-30 | $69.07M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $73.03M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $16.23M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $25.94M 10-K · filed 2023-03-06 |
| 2022-09-30 | $27.95M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $29.91M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $31.86M 10-Q · filed 2022-05-12 |
| 2022-01-01 | $33.40M 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |